Next week’s economic reports presented by Fawad Razaqzada, Market Analyst, Forex.com....
Are These the Best 5 UK Stocks?
05/17/2013 7:00 am EST
Harvey Jones of The Motley Fool UK singles out this diverse group of London-traded success stories, hoping that the market hasn't driven them too high.
For the last few months, I've been working my way through the FTSE-100, working out which stocks I would like to buy. Here are five stocks that have caught my eye.
When I sized up fashion chain Next (London: NXT) in early January, I liked the cut of its cloth.
Profits had risen 2.3% in 2012 to £625 million ($955 million), a veritable triumph for a retailer these days. Management had just predicted "subdued but steady" market conditions, but that didn't trouble the market.
Next's share price had just soared 50% to £39 over just 12 months. Four months later, it trades at a cool £46. Over five years, it is up an incredible 269%.
Its online Directory business is growing strongly, with sales up 8.9% in the first quarter, helping offset a 2% drop in retail sales, largely due to the icy spring.
Next yields just 2.3%, but management recently hiked that by a progressive 17%. This stock rocked in January. If consumer confidence continues to recover, there could be more fun to come. And it's not too expensive, at 15.5 times earnings.
Aberdeen Asset Management
Few publicly quoted companies are directly underpinned by the government in the same way as fund managers, with QE and loose monetary policy turbocharging stock market growth and company profits.
It's been a bumper few years for Aberdeen Asset Management (London: ADN), with the share price up 236% in the last three years, against just 27% for the FTSE-100 as a whole.
The success story continues, with its share price instantly rising 9% on publication of its half-year results at the end of April. Highlights included a 25% increase in revenue to £516 million, 37% growth in profits before tax, and a 36% hike in the dividend.
Aberdeen is expensive, at 19 times earnings. But I foresee further growth, at least until central bankers turn the taps off.
Back in January, international brewing giant SABMiller (London: SAB) struck me as a premium-strength company, trading at a premium price.
The global thirst for brands such as Bulmers, Coors, Foster's, Grolsch, Miller, Pilsner Urquell, and Strongbow has been a shot in the arm for the share price, with emerging-market giants putting in ever larger orders.
My worry then was that the share price looking a little toppy, at 20 times earnings and a yield of just 1.9%. It's even more toppy today, at nearly 26 times earnings, while the yield has sunk to 1.6% (despite a recent 12% hike in the half-year dividend).
In April, full-year trading results showed group revenue up 10%, despite a slowdown in its largest market, Latin America, where final quarter volumes fell 1%. SABMiller is still a great company, but with a hefty price on its head.
Multinational household goods and pharmaceutical behemoth Reckitt Benckiser (London: RB) is one of those companies that always looks a little expensive. That's the price you pay for a solid brand, solid growth, and a solid yield. It currently trades at 17.9 and yields 2.8%, below the FTSE 100 average of 3.4%.
It's a growing presence in emerging markets, where strong demand for its health and hygiene products has helped fuel double-digit quarterly growth. A strong US flu season also helped.
Reckitt Benckiser is a defensive stock that grew 40% over the past 12 months, against 23% for the FTSE-100. It looks like a great long-term buy and hold, but if you're looking for a cheap entry point, you may have to be patient.
Cambridge-based ARM Holdings (London: ARM) combines big intellectual ideas with low costs, because it outsources the physical manufacturing of its highly-prized microchips.
Demand for its processors from Apple, Nintendo, Nokia, Samsung and Sony Ericsson has made this stock a ten-bagger in the last five years, but it costs an ARM and a leg, however, trading at a whopping 72 times earnings.
ARM recently posted an analyst-thrashing first-quarter update, but how long can this go on for? A fair bit longer, it seems, thanks to strong sales and fat royalties for its next-generation ARMv8, Mali, and big.LITTLE technology.
This is a great British success story, but you have to be brave to buy at this valuation.
Related Articles on GLOBAL
Recessionary numbers hit Eurozone as UK gets conditional Brexit extension, writes Fawad Razaqzada....
Lower bond yields and a weaker euro could boost European stocks, writes Fawad Razaqzada....
The Fed’s statement suggests weakness in the economy, along with concern over trade talks with...